Cargando…
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
Lipids such as ceramides and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer’s disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured in the plasm...
Autores principales: | Kim, Min, Nevado-Holgado, Alejo, Whiley, Luke, Snowden, Stuart G., Soininen, Hilkka, Kloszewska, Iwona, Mecocci, Patrizia, Tsolaki, Magda, Vellas, Bruno, Thambisetty, Madhav, Dobson, Richard J.B., Powell, John F., Lupton, Michelle K., Simmons, Andy, Velayudhan, Latha, Lovestone, Simon, Proitsi, Petroula, Legido-Quigley, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676755/ https://www.ncbi.nlm.nih.gov/pubmed/27911300 http://dx.doi.org/10.3233/JAD-160645 |
Ejemplares similares
-
Genetic Predisposition to Increased Blood Cholesterol and Triglyceride Lipid Levels and Risk of Alzheimer Disease: A Mendelian Randomization Analysis
por: Proitsi, Petroula, et al.
Publicado: (2014) -
Urinary metabolic phenotyping for Alzheimer’s disease
por: Kurbatova, Natalja, et al.
Publicado: (2020) -
Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
por: Leung, Rufina, et al.
Publicado: (2013) -
Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease
por: Proitsi, P, et al.
Publicado: (2015) -
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
por: Whiley, Luke, et al.
Publicado: (2021)